Cipher Pharmaceuticals Inc.

Locations:
  • Mississauga, Ontario
- www.cipherpharma.com
Industries:
  • Healthcare Facility
  • Medical/ Pharmaceuticals

Organization Profile

Cipher Pharmaceuticals (NASDAQ:CPHR; TSX:CPH) is a growing specialty pharmaceutical company focused on dermatology. Cipher acquires products that fulfill high unmet medical needs, manages the required clinical development and regulatory approval process, and markets those products either directly or through partners. Cipher’s key product, a novel version of the acne medication isotretinoin, is marketed as AbsoricaTM in the U.S. and Epurisâ in Canada. Since the Company was founded in 2000, Cipher has achieved regulatory marketing approval in the U.S. and Canada for all three original products and completed eight marketing partnerships, generating growing revenue streams and shareholder value. Cipher is building its dermatology franchise through product licensing and acquisitions.


For more information, please visit www.cipherpharma.com.

Contact Information

Tanja Vasiljevic
Tel: 416-815-0700 ext 279
TVasiljevic@tmxequicom.com

Market Performance

Latest News Releases